ThrIVe Drip Spa - West University
- NAD IV Therapy
- Vitamin IV Therapy
- IV Therapy
- Migraine Treatment
- Peptide Therapy
Houston, TX
Migraine care in Houston blends headache medicine anchored around Texas Medical Center, Memorial Hermann, Houston Methodist, and MD Anderson with integrative clinics offering IV magnesium, nerve blocks, and peptide protocols. Demand reflects a large energy-industry and international patient base.
Evidence-based care uses triptans, gepants, lasmiditan, and anti-CGRP monoclonals for acute and preventive treatment, plus onabotulinumtoxinA for chronic migraine and FDA-cleared neuromodulation devices. Regenerative and integrative adjuncts in Houston, Texas include IV magnesium, occipital and sphenopalatine ganglion blocks, ketamine infusions for refractory cases, and HBOT (investigational for cluster headache). Texas Medical Board and active compounding pharmacy ecosystem shapes prescribing and compounding authority.
With migraine clinics on Regenerated.com in Houston, patients can compare whether a clinic offers a proper headache workup, follows ICHD-3 criteria, and clearly distinguishes FDA-approved from off-label options.
Regulatory context
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
The Texas Medical Board investigates TMS clinics for supervision lapses, corporate practice violations, and off-label marketing. Texas enforces a strict corporate practice of medicine doctrine, typically requiring Professional Association or Professional Limited Liability Company structures for clinical ownership. The Texas attorney general enforces the Deceptive Trade Practices Act against misleading medical device advertising, including neurofeedback cure claims. Commercial insurers and Texas Medicaid typically require documented treatment-resistant depression before covering TMS for major depressive disorder.